Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1082926-04-2 | MDL No. : | N/A |
Formula : | C12H17NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YQAOJWVABSPUHQ-UHFFFAOYSA-N |
M.W : | 191.27 | Pubchem ID : | 53775392 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 61.73 |
TPSA : | 21.26 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.04 cm/s |
Log Po/w (iLOGP) : | 2.58 |
Log Po/w (XLOGP3) : | 2.01 |
Log Po/w (WLOGP) : | 1.78 |
Log Po/w (MLOGP) : | 2.01 |
Log Po/w (SILICOS-IT) : | 2.81 |
Consensus Log Po/w : | 2.24 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.41 |
Solubility : | 0.742 mg/ml ; 0.00388 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.08 |
Solubility : | 1.58 mg/ml ; 0.00825 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.86 |
Solubility : | 0.0263 mg/ml ; 0.000137 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.11 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H319 | Packing Group: | N/A |
GHS Pictogram: |
[ 1106941-26-7 ]
3-(2-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 38175-35-8 ]
3-(3-Methoxyphenyl)pyrrolidine
Similarity: 0.87
[ 1095545-66-6 ]
3-(3-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.85
[ 1616370-88-7 ]
2-(Piperidin-4-yl)phenol hydrochloride
Similarity: 0.79
[ 149986-58-3 ]
4-(3-Methoxybenzyl)piperidine hydrochloride
Similarity: 0.78
[ 1106941-26-7 ]
3-(2-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 38175-35-8 ]
3-(3-Methoxyphenyl)pyrrolidine
Similarity: 0.87
[ 1095545-66-6 ]
3-(3-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.85
[ 149986-58-3 ]
4-(3-Methoxybenzyl)piperidine hydrochloride
Similarity: 0.78
[ 1106941-26-7 ]
3-(2-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 1095545-66-6 ]
3-(3-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.85
[ 1616370-88-7 ]
2-(Piperidin-4-yl)phenol hydrochloride
Similarity: 0.79
[ 149986-58-3 ]
4-(3-Methoxybenzyl)piperidine hydrochloride
Similarity: 0.78
[ 1106941-26-7 ]
3-(2-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 38175-35-8 ]
3-(3-Methoxyphenyl)pyrrolidine
Similarity: 0.87
[ 1095545-66-6 ]
3-(3-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.85
[ 1610028-40-4 ]
3-(3-Methoxyphenyl)pyrrolidine oxalate(2:1)
Similarity: 0.75
[ 1227798-75-5 ]
(R)-2-(4-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.72